Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Serrated adenocarcinoma

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Serrated adenocarcinoma (SAC) is more invasive, has worse outcomes than conventional colorectal carcinoma (CRC), and is… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2019
2019
To discern the differences in expression profiling of two histological subtypes of colorectal carcinoma (CRC) arising from the… Expand
2019
2019
Serrated adenocarcinoma (SAC) and colorectal carcinomas showing histological and molecular features of high-level of… Expand
2018
2018
BackgroundAltered methylation patterns are driving forces in colorectal carcinogenesis. The serrated adenocarcinoma (SAC) and… Expand
  • figure 1
  • figure 2
  • table 2
  • table 3
  • table 4
2016
2016
In the Western world, colorectal cancer (CRC) is one of the most common cancers and causes of cancer deaths. It is estimated that… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2015
2015
BackgroundSerrated adenocarcinoma (SAC) is a recently recognized colorectal cancer (CRC) subtype accounting for 7.5–8.7 % of CRCs… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
2014
2014
Serrated adenocarcinoma (SAC), representing at least 10 % of colorectal carcinomas (CRC), differs from conventional carcinomas… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
2013
2013
Olfactomedin 4 is a useful marker for stem cells in the intestine and is an independent prognostic molecule for survival in… Expand
2012
2012
Objective: Serrated adenocarcinoma (SAC), proposed as a new pathologic type, arises predominantly in the right side of the colon… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
2011
2011
García‐Solano J, Conesa‐Zamora P, Trujillo‐Santos J, Mäkinen M J & Pérez‐Guillermo M 
(2011) Histopathology 59, 1046–1056 
Tumour… Expand